Skip to main content

Table 2 HIV-1 Drug Resistance Associated Mutations (DRAMs) in the study participants

From: Emergence of HIV-1 drug resistance mutations in mothers on treatment with a history of prophylaxis in Ghana

Participant groups

Reverse transcriptase DRAMs

NRTIs

NNRTIs

Art after prophylaxis (Group 1)

M184 V

K103 N,Y181C

M41 L,M184 V, T215Y

K103 N,M230 L,A98G,

M41 L,M184 V,T215Y

K103 N A98G,

M41 L,M184 V,T215Y

A98G, K103 N

M41 L,M184MV,T215Y

A98G,K103 N,M230 LM

M41 L,M184MV,T215Y

A98G,K103 N,M230 LM

M41 L,L74 V,T215Y

K103 N, A98G,L100IL,,M230 L

K219KR

G190EG

Drug naïve group (Group 2)

V75S

E138A

NONE

A98G

M184 V

K103 N

L210 W

V106A

Art without prophylaxiS (Group 3)

M184 V,Y115F,T215S

A98G

M41 LM,D67G,K70R,K219E,T215I,M184 V

A98G

M184 V

NONE

  1. DRAMS Drug Resistance-Associated Mutations to Reverse Transcriptase Inhibitors
Back to article page

Virology Journal

ISSN: 1743-422X